2023-25947. Bulk Manufacturer of Controlled Substances Application: Isosciences, LLC  

  • Start Preamble Start Printed Page 82400

    AGENCY:

    Drug Enforcement Administration, Justice.

    ACTION:

    Notice of application.

    SUMMARY:

    Isosciences, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

    DATES:

    Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before January 23, 2024. Such persons may also file a written request for a hearing on the application on or before January 23, 2024.

    ADDRESSES:

    The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment.

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In accordance with 21 CFR 1301.33(a), this is notice that on October 25, 2023, Isosciences, LLC, 340 Mathers Road, Ambler, Pennsylvania 19002–3420, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s):

    Controlled substanceDrug codeSchedule
    Cathinone1235I
    Methcathinone1237I
    Lysergic acid diethylamide7315I
    Marihuana7360I
    Tetrahydrocannabinols7370I
    3,4-Methylenedioxyamphetamine7400I
    3,4-Methylenedioxy-N-ethylamphetamine7404I
    3,4-Methylenedioxymethamphetamine7405I
    5-Methoxy-N-N-dimethyltryptamine7431I
    Alpha-methyltryptamine7432I
    Bufotenine7433I
    Diethyltryptamine7434I
    Dimethyltryptamine7435I
    Psilocybin7437I
    Psilocyn7438I
    5-Methoxy-N,N-diisopropyltryptamine7439I
    Dihydromorphine9145I
    Heroin9200I
    Nicocodeine9309I
    Nicomorphine9312I
    Normorphine9313I
    Thebacon9315I
    Normethadone9635I
    Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide)9811I
    Para-Fluorofentanyl9812I
    3-Methylfentanyl9813I
    Alpha-methylfentanyl9814I
    Acetyl-alpha-methylfentanyl9815I
    N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide9816I
    Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)9821I
    Butyryl Fentanyl9822I
    4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide)9824I
    2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide9825I
    Beta-hydroxyfentanyl9830I
    Beta-hydroxy-3-methylfentanyl9831I
    Alpha-methylthiofentanyl9832I
    3-Methylthiofentanyl9833I
    Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide)9834I
    Thiofentanyl9835I
    Beta-hydroxythiofentanyl9836I
    N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide9843I
    Amphetamine1100II
    Methamphetamine1105II
    Codeine9050II
    Dihydrocodeine9120II
    Oxycodone9143II
    Hydromorphone9150II
    Hydrocodone9193II
    Isomethadone9226II
    Methadone9250II
    Methadone intermediate9254II
    Start Printed Page 82401
    Morphine9300II
    Thebaine9333II
    Levo-alphacetylmethadol9648II
    Oxymorphone9652II
    Thiafentanil9729II
    Alfentanil9737II
    Sufentanil9740II
    Carfentanil9743II
    Fentanyl9801II

    The company plans to manufacture bulk controlled substances for use in analytical testing. In reference to drug codes 7360 (Marihuana) and 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetics. No other activities for these drug codes are authorized for this registration.

    Start Signature

    Claude Redd,

    Acting Deputy Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2023–25947 Filed 11–22–23; 8:45 am]

    BILLING CODE P

Document Information

Published:
11/24/2023
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of application.
Document Number:
2023-25947
Dates:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before January 23, 2024. Such persons may also file a written request for a hearing on the application on or before January 23, 2024.
Pages:
82400-82401 (2 pages)
Docket Numbers:
Docket No. DEA-1292
PDF File:
2023-25947.pdf